These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9920008)

  • 1. Gene therapy for rheumatic diseases.
    Evans CH; Ghivizzani SC; Kang R; Muzzonigro T; Wasko MC; Herndon JH; Robbins PD
    Arthritis Rheum; 1999 Jan; 42(1):1-16. PubMed ID: 9920008
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cells in the aetiopathogenesis and therapy of rheumatic disease.
    Moore J; Tyndall A; Brooks P
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):711-26. PubMed ID: 11812017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotides: a new resource in rheumatology?
    Chary-Valckenaere I; Porumb H; Taillandier E; Pourel J
    Rev Rhum Engl Ed; 1998 Oct; 65(10):543-5. PubMed ID: 9809355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cold and heat therapy].
    Fahrer H
    Ther Umsch; 1985 Oct; 42(10):719-22. PubMed ID: 3909496
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of outcome measures in autoimmune rheumatic diseases.
    Mosca M; Baldini C; Bombardieri S
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S56-7. PubMed ID: 15309798
    [No Abstract]   [Full Text] [Related]  

  • 6. Is minimal clinically important difference relevant for the interpretation of clinical trials in pediatric rheumatic diseases?
    Ruperto N
    J Rheumatol; 2007 Mar; 34(3):463-5. PubMed ID: 17343299
    [No Abstract]   [Full Text] [Related]  

  • 7. How is clinical progress achieved?
    Klareskog L; Lindblad S
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):1-5. PubMed ID: 15123033
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fangotherapy in chronic degenerative rheumatic diseases].
    Grassi M; Lucchetta MC; Rini GB; Raffa S
    Clin Ter; 2003; 154(1):45-8. PubMed ID: 12854283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary treatments in rheumatic diseases.
    Ernst E
    Rheum Dis Clin North Am; 2008 May; 34(2):455-67. PubMed ID: 18638686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental rheumatology--on the way to a fundamental understanding of rheumatic diseases].
    Radbruch A
    Z Rheumatol; 2005 Sep; 64(6):367-9. PubMed ID: 16184342
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regulatory T cells in rheumatic diseases].
    Humrich J; Riemekasten G
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2288-91. PubMed ID: 17036273
    [No Abstract]   [Full Text] [Related]  

  • 12. [Future oriented clinical research: gene therapy].
    Zahlten RN; Labs RA
    Dtsch Med Wochenschr; 2000 Apr; 125(17):A25-9. PubMed ID: 10847775
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic and therapeutic standards for rheumatic diseases in children].
    Prusek W
    Pol Merkur Lekarski; 2002 Feb; 12(68):152-6. PubMed ID: 11995255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy chronology.
    During M
    Science; 1996 Jul; 273(5274):416-7. PubMed ID: 8677433
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell epitope-specific immune therapy for rheumatic diseases.
    Albani S; Prakken B
    Arthritis Rheum; 2006 Jan; 54(1):19-25. PubMed ID: 16385493
    [No Abstract]   [Full Text] [Related]  

  • 16. B-cell depletion for rheumatic diseases: where are we?
    Cohen SB
    MedGenMed; 2005 Jun; 7(2):72. PubMed ID: 16369450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new pyrazol derivative in the treatment of certain rheumatic diseases; clinical trials].
    SCHIAVETTI A; SCHIAVETTI L
    Minerva Med; 1958 Dec; 49(103):4865-9. PubMed ID: 13622412
    [No Abstract]   [Full Text] [Related]  

  • 18. Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease.
    Flynn A; O'Brien T
    IDrugs; 2008 Apr; 11(4):283-93. PubMed ID: 18379964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new synthetic steroid, metacortandracin, in therapy of rheumatic diseases; clinical cases and laboratory research].
    ROBECCHI A; DANEO V; MARRAZZI G
    Minerva Med; 1955 May; 46(41):1457-70. PubMed ID: 14393828
    [No Abstract]   [Full Text] [Related]  

  • 20. Primer: assessing the efficacy and safety of nonpharmacologic treatments for chronic rheumatic diseases.
    Ravaud P; Boutron I
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):313-9. PubMed ID: 16932710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.